Table 1.
Schizophrenia patients | Healthy controls | |
---|---|---|
Subjects (n) | 8 | 8 |
Age in years (mean ± SD) | 33.9 ± 11.4 | 32.4 ± 13.9 |
Gender (M/F) | 6/2 | 5/3 |
SE median (IQR) | 9 (4.5) | 5.5 (4.5) |
Months since diagnosis | 104 ± 86 | NC |
Paranoid schizophrenia* | 7/8 | NC |
FGA | 2/8 | NC |
SGA | 4/8 | NC |
FGA + SGA | 1/8 | NC |
AED (daily mg of CPZ)** | 296 ± 87 | NC |
SE, socioeconomic decile; IQR, interquartile range; FGA, first generation antipsychotics; SGA, second generation antipsychotics; AED, antipsychotic equivalent dose. *One patient data could not be retrieved. **Based on Kroken et al., 2009 (see Materials and Methods).